9 million market cap
5.6 million in cash and around 4 million dollar research and development rebate coming in second half of the year
10 million in funding. Keep shorting the 10 million dollars in cash they have will be for free for all share holders. Keep selling, tell the geniuses to keep going
- Forums
- ASX - By Stock
- NYR
- Ann: Significant Neuroprotection in NYR Preclinical Brain Injury
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury, page-191
Featured News
Add NYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.05M |
Open | High | Low | Value | Volume |
11.0¢ | 11.5¢ | 11.0¢ | $102.4K | 923.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 1382857 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 39607 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1332857 | 0.105 |
22 | 1294853 | 0.100 |
2 | 59671 | 0.099 |
1 | 60000 | 0.098 |
1 | 14000 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 39607 | 1 |
0.115 | 283793 | 6 |
0.120 | 300000 | 2 |
0.125 | 474415 | 6 |
0.130 | 210000 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online